PRA number
2017/16353
Published date
Product description
One lot only - 1078155. The lot number is displayed on the left side of the front panel of the packs (see image).
Expiry 31/12/2019
Supplied from 2 August 2017
Lucrin Depot Paediatric 30mg PDS is used to treat central precocious puberty, a condition causing children to enter puberty prematurely.
AUST R: 218936
Expiry 31/12/2019
Supplied from 2 August 2017
Lucrin Depot Paediatric 30mg PDS is used to treat central precocious puberty, a condition causing children to enter puberty prematurely.
AUST R: 218936
What are the defects?
Potential for incomplete delivery of medication.
The batch is being recalled due to reports of the active ingredient powder not dissolving sufficiently with the diluent liquid in the syringe, causing clumping. The clumping is readily visible to the naked eye in affected products and should be noticed on inspection.
The batch is being recalled due to reports of the active ingredient powder not dissolving sufficiently with the diluent liquid in the syringe, causing clumping. The clumping is readily visible to the naked eye in affected products and should be noticed on inspection.
What are the hazards?
If the contents of the syringe are injected, it could result in the incomplete delivery of medication and the patient receiving a sub-therapeutic dose. Injection of affected medication could also result in increased irritation or reaction at the injection site.
What should consumers do?
If you, or somebody you care for, is taking Lucrin Depot Paediatric 30mg PDS, please be alert to this issue. Check any prefilled syringes that you have and if they are from lot number 1078155, return them to your pharmacy for refund or replacement. All pre-filled syringes should be routinely inspected before use and if you notice anything unusual, consult a health professional.
Further information is available from AbbVie Medical Information on 1800 043 460.
Further information is available from AbbVie Medical Information on 1800 043 460.
Supplier
Where the product was sold
New South Wales
Queensland
Victoria
Responsible regulator
Therapeutic Goods Administration is the responsible regulator for this recall.